Health facility characteristics and their relationship to coverage of PMTCT of HIV services across four African countries: the PEARL study

Didier K Ekouevi, Elizabeth Stringer, David Coetzee, Pius Tih, Tracy Creek, Kathryn Stinson, Andrew O Westfall, Thomas Welty, Namwinga Chintu, Benjamin H Chi, Cathy Wilfert, Nathan Shaffer, Jeff Stringer, Francois Dabis, Didier K Ekouevi, Elizabeth Stringer, David Coetzee, Pius Tih, Tracy Creek, Kathryn Stinson, Andrew O Westfall, Thomas Welty, Namwinga Chintu, Benjamin H Chi, Cathy Wilfert, Nathan Shaffer, Jeff Stringer, Francois Dabis

Abstract

Background: Health facility characteristics associated with effective prevention of mother-to-child transmission of HIV (PMTCT) coverage in sub-Saharan are poorly understood.

Methodology/principal findings: We conducted surveys in health facilities with active PMTCT services in Cameroon, Cote d'Ivoire, South Africa, and Zambia. Data was compiled via direct observation and exit interviews. We constructed composite scores to describe provision of PMTCT services across seven topical areas: antenatal quality, PMTCT quality, supplies available, patient satisfaction, patient understanding of medication, and infrastructure quality. Pearson correlations and Generalized Estimating Equations (GEE) to account for clustering of facilities within countries were used to evaluate the relationship between the composite scores, total time of visit and select individual variables with PMTCT coverage among women delivering. Between July 2008 and May 2009, we collected data from 32 facilities; 78% were managed by the government health system. An opt-out approach for HIV testing was used in 100% of facilities in Zambia, 63% in Cameroon, and none in Côte d'Ivoire or South Africa. Using Pearson correlations, PMTCT coverage (median of 55%, (IQR: 33-68) was correlated with PMTCT quality score (rho = 0.51; p = 0.003); infrastructure quality score (rho = 0.43; p = 0.017); time spent at clinic (rho = 0.47; p = 0.013); patient understanding of medications score (rho = 0.51; p = 0.006); and patient satisfaction quality score (rho = 0.38; p = 0.031). PMTCT coverage was marginally correlated with the antenatal quality score (rho = 0.304; p = 0.091). Using GEE adjustment for clustering, the, antenatal quality score became more strongly associated with PMTCT coverage (p<0.001) and the PMTCT quality score and patient understanding of medications remained marginally significant.

Conclusions/results: We observed a positive relationship between an antenatal quality score and PMTCT coverage but did not identify a consistent set of variables that predicted PMTCT coverage.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Relationship between composite ANC score…
Figure 1. Relationship between composite ANC score and PMTCT coverage.
PEARL Facility Survey, 2007–2009.
Figure 2. Relationship of composite PMTCT score…
Figure 2. Relationship of composite PMTCT score and PMTCT coverage, PEARL Facility Survey, 2007–2009.
Areas of the circles are proportional to the size of the cord blood sample used to estimate PMTCT coverage Line is based on the GEE model that accounts for clustering.

References

    1. WHO/UNAIDS/UNICEF. Towards Universal Access. Scaling up priority HIV/AIDS interventions in the health sector. 2009. Progress Report June 2009.; Available: . Accessed: 24 October 2011.
    1. Doherty TM, McCoy D, Donohue S. Health system constraints to optimal coverage of the prevention of mother-to-child HIV transmission programme in South Africa: lessons from the implementation of the national pilot programme. Afr Health Sci. 2005;3:213–8.
    1. Ekouevi DK, Leroy V, Viho A, Bequet L, Horo A, et al. Acceptability and uptake of a package to prevent mother-to-child transmission using rapid HIV testing in Abidjan, Cote d'Ivoire. AIDS. 2004;4:697–700.
    1. Rollins N, Little K, Mzolo S, Horwood C, Newell ML. Surveillance of mother-to-child transmission prevention programmes at immunization clinics: the case for universal screening. Aids. 2007;10:1341–7.
    1. Stringer EM, Ekouevi DK, Coetzee D, Tih PM, Creek TL, et al. Coverage of nevirapine-based services to prevent mother-to-child HIV transmission in 4 African countries. JAMA. 2011;3:293–302.
    1. WHO. Recommendations for use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. 2010. Guidelines on care, treatment and support for women living with HIV/AIDS and their children in resource-constrained settings. 2010. Available: . Accessed: 01 October 2011.
    1. Mandala J, Torpey K, Kasonde P, Kabaso M, Dirks R, et al. Prevention of mother-to-child transmission of HIV in Zambia: implementing efficacious ARV regimens in primary health centers. BMC Public Health. 2009;2009 Aug 27;9:314.
    1. Oladapo OT, Iyaniwura CA, Sule-Odu AO. Quality of antenatal services at the primary care level in southwest Nigeria. Afr J Reprod Health. 2008;3:71–92.
    1. Creek TL, Ntumy R, Seipone K, Smith M, Mogodi M, et al. Successful introduction of routine opt-out HIV testing in antenatal care in Botswana. J Acquir Immune Defic Syndr. 2007;1:102–7.
    1. Chandisarewa W, Stranix-Chibanda L, Chirapa E, Miller A, Simoyi M, et al. Routine offer of antenatal HIV testing (“opt-out” approach) to prevent mother-to-child transmission of HIV in urban Zimbabwe. Bull World Health Organ. 2007;11:843–50.

Source: PubMed

3
Suscribir